TW200613317A - Steroid prodrugs with androgenic action - Google Patents

Steroid prodrugs with androgenic action

Info

Publication number
TW200613317A
TW200613317A TW094116504A TW94116504A TW200613317A TW 200613317 A TW200613317 A TW 200613317A TW 094116504 A TW094116504 A TW 094116504A TW 94116504 A TW94116504 A TW 94116504A TW 200613317 A TW200613317 A TW 200613317A
Authority
TW
Taiwan
Prior art keywords
androgenic action
steroid
steroid prodrugs
prodrugs
androgenic
Prior art date
Application number
TW094116504A
Other languages
English (en)
Chinese (zh)
Inventor
Peter Droescher
Walter Elger
Alexander Hillisch
Gudrun Reddersen
Sven Ring
Birgitt Schneider
Ralf Wyrwa
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of TW200613317A publication Critical patent/TW200613317A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0044—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an estrane or gonane skeleton, including 18-substituted derivatives and derivatives where position 17-beta is substituted by a carbon atom not directly bonded to another carbon atom and not being part of an amide group

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
TW094116504A 2004-05-21 2005-05-20 Steroid prodrugs with androgenic action TW200613317A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004025986A DE102004025986A1 (de) 2004-05-21 2004-05-21 Steroid-Prodrugs mit androgener Wirkung

Publications (1)

Publication Number Publication Date
TW200613317A true TW200613317A (en) 2006-05-01

Family

ID=34968657

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094116504A TW200613317A (en) 2004-05-21 2005-05-20 Steroid prodrugs with androgenic action

Country Status (22)

Country Link
EP (1) EP1747229A1 (pt)
JP (1) JP2007538026A (pt)
CN (1) CN1993375A (pt)
AR (1) AR049547A1 (pt)
AU (1) AU2005245568A1 (pt)
BR (1) BRPI0510136A (pt)
CA (1) CA2564963A1 (pt)
CR (1) CR8785A (pt)
DE (1) DE102004025986A1 (pt)
EA (1) EA200602049A1 (pt)
EC (1) ECSP067028A (pt)
GT (1) GT200500122A (pt)
IL (1) IL179293A0 (pt)
MX (1) MXPA06013469A (pt)
NO (1) NO20065885L (pt)
PA (1) PA8633601A1 (pt)
PE (1) PE20060271A1 (pt)
SV (1) SV2006002123A (pt)
TW (1) TW200613317A (pt)
UY (1) UY28911A1 (pt)
WO (1) WO2005113575A1 (pt)
ZA (1) ZA200610769B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10027887A1 (de) 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
US7534780B2 (en) 2004-05-21 2009-05-19 Bayer Schering Pharma Aktiengesellschaft Estradiol prodrugs
DE102005057224A1 (de) * 2005-11-29 2007-05-31 Bayer Schering Pharma Ag Prodrugs ERß-selektiver Substanzen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE102005057408A1 (de) * 2005-11-30 2007-05-31 Bayer Schering Pharma Ag Sulfamoylsulfonat-Prodrugs
CN101708338B (zh) * 2008-12-26 2014-06-04 中国人民解放军军事医学科学院放射与辐射医学研究所 含甾体结构的前药及其高度分散制剂
CN102964417A (zh) * 2012-11-30 2013-03-13 华中药业股份有限公司 17-羟基四氢吡喃醚甾族化合物的合成方法
CN107556258B (zh) * 2017-08-22 2021-06-04 湖北江田精密化学有限公司 一种4-氨基-2-氯-5(1h-四唑基-5)苯磺酰胺的制备方法
EP3533619A1 (en) 2018-03-02 2019-09-04 Basf Se Heat sensitive recording material and color developer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH545316A (de) * 1970-07-17 1973-12-15 Hoffmann La Roche Verfahren zur Herstellung von Acylderivaten
US5001234A (en) * 1987-04-16 1991-03-19 The Upjohn Company Cyclic hydrocarbons with an aminoalkyl sidechain
US5571933A (en) * 1994-11-17 1996-11-05 Duquesne University Of The Holy Ghost Derivatives of estra 1,3,5(10)triene-17-one, 3-amino compounds and their use
DE19712488A1 (de) * 1997-03-25 1998-10-01 Knoell Hans Forschung Ev Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben
DE10027887A1 (de) * 2000-05-31 2001-12-13 Jenapharm Gmbh Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen

Also Published As

Publication number Publication date
ECSP067028A (es) 2006-12-29
MXPA06013469A (es) 2007-01-23
EA200602049A1 (ru) 2007-06-29
UY28911A1 (es) 2005-12-30
GT200500122A (es) 2006-01-24
DE102004025986A1 (de) 2005-12-15
AR049547A1 (es) 2006-08-16
NO20065885L (no) 2006-12-19
CN1993375A (zh) 2007-07-04
BRPI0510136A (pt) 2007-10-02
JP2007538026A (ja) 2007-12-27
AU2005245568A1 (en) 2005-12-01
CA2564963A1 (en) 2005-12-01
PE20060271A1 (es) 2006-05-25
PA8633601A1 (es) 2006-07-03
SV2006002123A (es) 2006-02-15
EP1747229A1 (de) 2007-01-31
ZA200610769B (en) 2008-08-27
CR8785A (es) 2007-02-05
WO2005113575A1 (de) 2005-12-01
IL179293A0 (en) 2007-03-08

Similar Documents

Publication Publication Date Title
MX2011011661A (es) Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750.
MX2011012366A (es) Mezclas fungicidas sinergeticas.
TNSN07360A1 (en) Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof
TW200716606A (en) Chemical compounds
TW200800963A (en) Chemical compounds
PL1853602T3 (pl) Związki chemiczne
SI1853588T1 (sl) Kemične spojine
MX339476B (es) Compuestos que incluyen un nucleo farmaceutico antiinflamatorio y sus metodos de uso.
GEP20146125B (en) Aminopyrimidines as syk inhibitors
MY148253A (en) Azaadamantane derivatives and methods of use
SG163585A1 (en) Melanocortin receptor ligands
MX2009004746A (es) Derivados de 1,2,4-triazol como inhibidores del receptor sigma.
GB0625648D0 (en) Compounds
TW200745084A (en) Novel compounds
MX2009007713A (es) Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas.
MY149512A (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
TNSN08370A1 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
MX2010009022A (es) Derivados 16 alfa, 17 alfa-acetal glucocorticoesteroideos y su uso.
JO2682B1 (en) Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof
MY151017A (en) 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1h-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents
SG158091A1 (en) Imidazoazepinone compounds
ZA200801875B (en) Isoquinolines as IGF-IR inhibitors
MX346980B (es) Nuevos compuestos de hexahidrociclopentapirrolona, hexahidropirrolopirrolona, octahidropirrolopiridinona y octahidropiridinona.
TW200745122A (en) New compounds I
MX2009009831A (es) Nitrilos aromatizantes.